𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Management of testicular seminoma following organ transplantation

✍ Scribed by Villalona-Calero, Miguel A. ;Ducker, Thomas ;Holasek, Maureen ;Najarian, John ;Kennedy, B. J.


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
260 KB
Volume
20
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

An increased incidence of malignancies has occurred in recipients of organ transplantation who are immunosuppressed. Although testicular cancers have been uncommon, seminomas are extremely rare. Two patients with long‐standing diabetes mellitus and renal transplants developed clinical stage I seminoma of the testis. These patients posed a therapeutic problem with respect to the use of radiation therapy. In one, none was given because of a combination of kidney rejection and antibiotic‐induced renal damage. The second patient received radiation therapy with shielding of the transplanted kidney. The surgical distortion of lymph node architecture increases the problems in the use of radiation therapy. Individual factors need to be considered in the use of postorchiectomy radiation therapy for seminoma in transplant patients. Β© 1992 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Management of testicular seminoma
✍ Michael F. Milosevic; Mary Gospodarowicz; Padraig Warde πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 122 KB πŸ‘ 1 views

Testicular seminoma is highly curable with currently available treatments. Today, there is good evidence that patients with Stage I disease can be treated equally well with either immediate adjuvant para-aortic and ipsilateral pelvic radiotherapy or close surveillance with treatment at the time of r

Controversies in the management of testi
✍ Dr. Gillian M. Thomas πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 702 KB

The 5-year cause specific actuarial survival rate for 178 patients treated for testicular seminoma at The Princess Margaret Hospital 1977 to 1981 is 97%. Controversies exist over how to optimally use and integrate chemotherapy (a) and radiation therapy ( R I ) to minimize morbidity and achieve these

Radiation-induced tumors in irradiated s
✍ Stein, Moshe E.; Leviov, Michelle; Drumea, Keren; Moshkovitz, Boaz; Nativ, Ofer; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 22 KB πŸ‘ 2 views

Background and Objectives: Testicular seminoma is a very radiosensitive and curable cancer, with survival rates following radiation therapy within the range of 90-98% without apparent severe side effects. However, long-term survival following exposure to moderate-dose radiation therapy can result in

Modern management of respiratory failure
✍ Michael Koldehoff; Johames L. Zakrzewski πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 2 views

## Abstract Pulmonary mycoses count among the most dangerous complications in allogeneic hematopoietic stem cell transplantation. Despite the establishment of antifungal chemoprophylaxis and empirical antifungal treatment, they frequently lead to respiratory failure and are still associated with an

Transjugular intrahepatic portosystemic
✍ M W Fried; D G Connaghan; S Sharma; L G Martin; S Devine; K Holland; A Zuckerman πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 374 KB

tension with ascites frequently accompanies these histologi-Hepatic venoocclusive disease (VOD) is a common, lifecal changes and contributes to the clinical manifestations of threatening complication of bone marrow transplantathis syndrome. A wedged hepatic venous pressure gradient tion (BMT). Porta

Role of fine-needle aspiration in the cl
✍ Gattuso, Paolo ;Reddy, Vijaya B. ;Kizilbash, Nava ;Kluskens, Larry ;Selvaggi, Su πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 447 KB πŸ‘ 2 views

## BACKGROUND. We evaluated the clinical course of the solid-organ transplant population at our institutions to determine the role of fine-needle aspiration (FNA) in the clinical management of this subgroup of patients. . 1196 allograft recipients (522 liver, 288 cardiac, 250 renal, 131 lung, 5 he